SLE - SYSTEMIC LUPUS ERYTHEMATOSUS
Clinical trials for SLE - SYSTEMIC LUPUS ERYTHEMATOSUS explained in plain language.
Never miss a new study
Get alerted when new SLE - SYSTEMIC LUPUS ERYTHEMATOSUS trials appear
Sign up with your email to follow new studies for SLE - SYSTEMIC LUPUS ERYTHEMATOSUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough lupus: scientists test 'Living Drug' made from donated cord blood
Disease control Recruiting nowThis early-stage study is testing a new type of treatment called CAR-T cell therapy for adults with severe lupus that hasn't improved with standard medications. The therapy involves collecting immune cells from donated umbilical cord blood, modifying them in a lab to target lupus…
Matched conditions: SLE - SYSTEMIC LUPUS ERYTHEMATOSUS
Phase: EARLY_PHASE1 • Sponsor: Chengdu Ucello Biotechnology Co., Ltd. • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
First test of new lupus drug begins in patients
Disease control Recruiting nowThis is the first human study of an experimental drug called CC312 for people with moderate-to-severe lupus. The main goal is to check the safety and side effects in 32 participants, and see how the body processes the drug. Researchers will also look for early signs that it might…
Matched conditions: SLE - SYSTEMIC LUPUS ERYTHEMATOSUS
Phase: PHASE1 • Sponsor: CytoCares Inc • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Real-World study tests if lupus drug shields vital organs
Disease control Recruiting nowThis study aims to see if the drug belimumab can prevent serious organ damage in people with systemic lupus erythematosus (SLE). Researchers will compare 684 patients taking belimumab to similar patients receiving only standard care, using real-world medical records to track who …
Matched conditions: SLE - SYSTEMIC LUPUS ERYTHEMATOSUS
Sponsor: Biomedical Research Foundation, Academy of Athens • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC
-
Radical cell therapy tested for lupus patients out of options
Disease control Recruiting nowThis early-stage trial is testing a new cell therapy called MB-CART19.1 for adults with severe systemic lupus that hasn't responded to standard treatments. The study aims to find a safe dose and see if the therapy can put lupus into remission. It involves genetically modifying a …
Matched conditions: SLE - SYSTEMIC LUPUS ERYTHEMATOSUS
Phase: PHASE1, PHASE2 • Sponsor: Miltenyi Biomedicine GmbH • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC
-
Scientists test 'Off-the-Shelf' cell therapy to reset immune system in devastating autoimmune diseases
Disease control Recruiting nowThis early-phase study is testing a new type of cell therapy called QT-019C for people with severe autoimmune diseases that have not improved with standard treatments. The therapy uses donated, 'universal' immune cells engineered to target and remove harmful immune cells. The mai…
Matched conditions: SLE - SYSTEMIC LUPUS ERYTHEMATOSUS
Phase: PHASE1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Mar 13, 2026 15:05 UTC
-
New drug tested for patients with severe autoimmune diseases who have run out of options
Disease control Recruiting nowThis is a very early study to check the safety and initial effects of an experimental drug called CC312. It is for adults with severe, relapsed forms of lupus, myositis, or scleroderma that have not improved with standard treatments. The main goal is to find a safe dose and see h…
Matched conditions: SLE - SYSTEMIC LUPUS ERYTHEMATOSUS
Phase: EARLY_PHASE1 • Sponsor: CytoCares Inc • Aim: Disease control
Last updated Mar 11, 2026 14:53 UTC